Geoffrey Shiu Fei Ling's Insider Trades & SAST Disclosures
Geoffrey Shiu Fei Ling's most recent trade in Celularity Inc - Ordinary Shares - Class A was a trade of 84,746 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Geoffrey Shiu Fei Ling.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celularity Inc - Ordinary ... | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 84,746 | 1,334,746 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc - Ordinary ... | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 67,416 | 67,416 | - | 0 | Class A Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,855 | 31,790 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 2,858 | 18,935 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 2,713 | 16,077 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 2,331 | 13,364 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 1,782 | 11,033 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 2,616 | 9,251 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 1,703 | 6,635 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Geoffrey Shiu Fei Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges